DONATE

Search Results for:

IBEC-led consortium develops light-activated drugs that restore sight in blind mice

A consortium led by the Institute for Bioengineering of Catalonia (IBEC) developed this approach based on photopharmacology, a technique to reversibly control drug activity with light. The newly developed compounds, called prosthe6, mimic the function of photoreceptor cells, which degenerate in blinding diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). These photoswitchable molecules show preliminary safety profiles and represent potential drug candidates for restoring vision in patients with degenerative retinal diseases, without the need for genetic manipulation or implanted devices.

IBEC to participate in Flagship European Grant for the Physics of Living Matter

Xavier Trepat and his team at the Institute for Bioengineering of Catalonia (IBEC) are key partners in ALIVE: Active Living Matter — Information, Vitality, and Emergence, an international research programme selected for funding through the first European edition of the Novo Nordisk Foundation Challenge Programme. Coordinated by the Niels Bohr Institute in Copenhagen, the project will receive 75 million DKK (around €10 million) over six years to uncover how information flows drive the emergence, organisation and function of living tissues.

Transversal Skills: Marta Rotxés and Alexia García

Clinical Trials: Understanding the Journey from Research to Patient Care. Clinical trials are at the heart of medical innovation, helping to bring new treatments and technologies to patients. In this seminar, … Read more